LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...
FDA open to pooling data from ongoing Phase I/II studies of LX2006 with data from pivotal trial, and to earlier co-primary ...
Is paying more than £300 for a full top-to-toe health check worth the money? Helen McGurk finds out with a visit to Randox ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Cambridge, Massachusetts Friday, October 24, 2025, 18:00 Hrs [IST] ...
Learn what the albumin blood test means for your health, how it’s done, and what low or high levels can reveal about your ...
Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...
Sleepless nights, clammy sheets and burning cheeks drain energy and confidence; a new approach promises calmer days for millions. After years of relying ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a potent and ...
A group of physicians from Ayurveda at Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan has recorded a rare medical success in cancer.
SurvivorNet on MSN
Powerful New Evidence Finds CDK4/6 Inhibitors Reduce Recurrence Risk In The Largest Sub-Group of Breast Cancer Patients
New research presented this year highlighted major advances for people with hormone-receptor–positive, HER2-negative breast cancer. Two large studies showed that CDK4/6 inhibitors—Verzenio ...
Caught between withdrawn donor funding and a rocky Social Health Authority rollout, Kenyans living with HIV are now forced to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback